GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 09/03/2011
PIL Menitorix

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 10/06/2009 and displayed until 09/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 12/06/2008 and displayed until 10/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 05/01/2006 and displayed until 12/06/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   hib meningococcal group c combined vaccine